Absence of Association Between Individual Thymidine Analogues or Nonnucleoside Analogues and Lipid Abnormalities in HIV-1–Infected Persons on Initial Therapy

This publication has 12 references indexed in Scilit:

• Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy
  AIDS, 1999
• Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
  The Lancet, 1999
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
  The Lancet, 1999
• Lipodystrophy associated with nevirapine-containing antiretroviral therapies
  AIDS, 1999
• Lipodystrophy in patients naive to HIV protease inhibitors
  AIDS, 1999
• Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: the lipodystrophy syndrome
  Current Opinion in Infectious Diseases, 1999
• Fat accumulation and HIV-1 protease inhibitors
  The Lancet, 1998
• Metabolic abnormalities and use of HIV-1 protease inhibitors
  The Lancet, 1998
• Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
  The Lancet, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998